EUVIMEDEUVIMED entdecken
Open Access

Twin-bioengine self-adaptive micro/nanorobots using enzyme actuation and macrophage relay for gastrointestinal inflammation therapy

Baozhen Zhang iD, Hong Pan iD, Ze Chen, Ting Yin iD, Mingbin Zheng iD, Lintao Cai iD

Science Advances · 24.02.2023 · 9 (8)

DOI: 10.1126/sciadv.adc8978 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 24.02.2023. Verfasst von Baozhen Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Key Laboratory of Nanomedicine, CAS-HK Joint Lab of Biomaterials, Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Scie…. Hauptthemen laut MEDLINE: Drug Delivery Systems, Macrophages. Die Arbeit wurde bisher 95-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A wide array of biocompatible micro/nanorobots are designed for targeted drug delivery and precision therapy largely depending on their self-adaptive ability overcoming complex barriers in vivo. Here, we report a twin-bioengine yeast micro/nanorobot (TBY-robot) with self-propelling and self-adaptive capabilities that can autonomously navigate to inflamed sites for gastrointestinal inflammation therapy via enzyme-macrophage switching (EMS). Asymmetrical TBY-robots effectively penetrated the mucus barrier and notably enhanced their intestinal retention using a dual enzyme-driven engine toward enteral glucose gradient. Thereafter, the TBY-robot was transferred to Peyer’s patch, where the enzyme-driven engine switched in situ to macrophage bioengine and was subsequently relayed to inflamed sites along a chemokine gradient. Encouragingly, EMS-based delivery increased drug accumulation at the diseased site by approximately 1000-fold, markedly attenuating inflammation and ameliorating disease pathology in mouse models of colitis and gastric ulcers. These self-adaptive TBY-robots represent a safe and promising strategy for the precision treatment of gastrointestinal inflammation and other inflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Delivery SystemsMacrophagesMiceAnimalsInflammationDisease Models, Animal

Autor:innen und Institutionen

  • Guangdong Key Laboratory of Nanomedicine, CAS-HK Joint Lab of Biomaterials, Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences (CAS), Shenzhen 518055, China.
  • University of Chinese Academy of Sciences, Beijing 100049, China.
  • National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, The Second Affiliated Hospital, Southern University of Science and Technology, Shenzhen 518112, China.

ORCID-Profile: Baozhen Zhang, Hong Pan, Ting Yin, Mingbin Zheng, Lintao Cai

Zitieren

APA

Zhang, B., Pan, H., Chen, Z., Yin, T., Zheng, M., & Cai, L. (2023). Twin-bioengine self-adaptive micro/nanorobots using enzyme actuation and macrophage relay for gastrointestinal inflammation therapy. Science Advances, 9(8). https://doi.org/10.1126/sciadv.adc8978

Vancouver

Zhang B, Pan H, Chen Z, Yin T, Zheng M, Cai L. Twin-bioengine self-adaptive micro/nanorobots using enzyme actuation and macrophage relay for gastrointestinal inflammation therapy. Science Advances. 2023;9(8). doi:10.1126/sciadv.adc8978

BibTeX
@article{Zhang2023,
  author = {Zhang, Baozhen and Pan, Hong and Chen, Ze and Yin, Ting and Zheng, Mingbin and Cai, Lintao},
  title = {Twin-bioengine self-adaptive micro/nanorobots using enzyme actuation and macrophage relay for gastrointestinal inflammation therapy},
  journal = {Science Advances},
  year = {2023},
  volume = {9},
  number = {8},
  doi = {10.1126/sciadv.adc8978}
}
Kostenlos starten →